The industry may be on the verge of facing up to potential ‘dry labbing’ issues, which could bring the issue to the forefront and ‘hopefully get this problem fixed’, says ChromaDex’s Frank Jaksch.
The U.S. Food and Drug Administration (FDA) found no deficiencies or areas where corrective action notices following a cGMP (current Good Manufacturing Practices) inspection of its facility in Utah.
EuroPharma is planning to launch a probe into commercially available curcumin supplements to establish whether products purporting to contain exclusively natural extracts in fact contain cheaper, synthetic raw materials.
ChromaDex has signed a deal with the Association for African Medicinal Plants Standards (AAMPS) to sell and market its botanical standards and the African Herbal Pharmacopoeia.
Scientists with the US Department of Agriculture (USDA) have developed a ‘simple, fast, and easy’ method to test for adulterants in skullcap herbal formulations, a timely development given potential short-comings with formulations currently on the market.
So-called Class 1 solvents such as benzene and carbon tetrachloride have no place in the manufacture of herbal products, the American Herbal Products Association (AHPA) has said.
The FDA should calculate how much complying with its guidance on new dietary ingredients (NDIs) will cost before forcing the supplements industry to embark on a “giant paperwork exercise” that will not make consumers any safer, according to the first...
The US arm of Israeli biotech firm Enzymotec says it is confident of sustaining double-digit growth in sales of krill oil as awareness of its multiple benefits grows.
Many dietary ingredients used in supplements today bear little resemblance to ingredients that were assumed to be ‘grandfathered in’ post the 1994 Dietary Supplements Health and Education Act, making a fresh safety analysis eminently reasonable if extraction...
Another leading supplier has weighed into the debate over unscrupulous firms peddling ‘krill oil’ that contains “next to no phospholipids” but says the development of a monograph and better testing protocols might go some way to tackling the problem.
The Office of Dietary Supplements (ODS) at the National Institutes of Health (NIH) is requesting proposals for "Analytical Methods Development, Optimization, and Validation: Dietary Supplement Constituents".
Unscrupulous firms peddling ‘krill oil’ that contains “next to no phospholipids” risk denting confidence in the efficacy of krill and the broader omega-3 market, a leading supplier has warned.
Supplements giant NBTY has admitted that being the subject of a Food and Drug Administration (FDA) warning letter this spring was “embarrassing”, but insists it has since addressed all of the outstanding issues raised by the regulator.
High doses of bitter orange (Citrus aurantium) are not toxic to mothers or their babies, according to a new toxicology study with rats from FDA that adds to the ingredient’s safety profile.
A flurry of seizures, criminal charges, and warning letters shows that FDA is increasing it enforcement of dietary supplement regulations. Good for FDA and good for industry!
The US Food and Drug Administration (FDA) has issued a warning letter to Florida-based Cerebral Health, LLC, for failing to comply with Current Good Manufacturing Practice (CGMP).
Dietary supplement trade associations have applauded the 'strong action' of the FDA and the Department of Justice for finding New Jersey-based dietary supplement companies guilty of criminal contempt of court relating to GMP violations.
A new series of white papers will help the dietary supplements trade wise up to the tricks used by unscrupulous suppliers to adulterate herbals and botanicals, American Botanical Council (ABC) founder Mark Blumenthal tells Elaine Watson.
Chondroitin remains one of the most adulterated dietary supplements on the shelf despite attempts by responsible companies to tackle the problem, according to a leading analytical testing firm.
Sports nutrition player BSN has received Good Manufacturing Practices (GMP) from NSF International following a distribution facility audit, the company has announced.
A Californian statute with the laudable aim of protecting consumers from potential carcinogens has in practice exposed even the most responsible players in the dietary supplements sector to the constant threat of ‘legalized blackmail’, legal experts have...
A case challenging the dietary supplement good manufacturing practice (GMP) regulations has been dismissed by the US District Court for the District of Columbia.
The chemical composition of commercially available green tea-based dietary supplements is not the same as green tea beverages, and some contain non-tea ingredients like fenugreek, says a new analysis from the USDA.
Connecticut-based dietary supplements manufacturer Vital Nutrients has written an open letter to its customers to assure them that the recent FDA warning letter it received over GMP issues were “predominantly of an administrative nature” and not a reflection...
Dietary supplement manufacturers operating in China will have to do more to guarantee the quality of their supply chains, after Chinese authorities imposed new quality control regulations last week.
A new test method may enhance the identification of adulterants in black cohosh products, and allay concerns over potential liver toxicity from the presence of other related herbal species in black cohosh formulations.
A new program allowing in-house raw material testing without any up-front capital costs, is 'an exciting opportunity for industry', says Chromadex's VP of corporate development.
The Food and Drug Administration (FDA) today issued a statement warning consumers to “beware of fraudulent dietary supplements” as its labelling, GMP and AER crackdown continues.
The Food and Drug Administration (FDA) has issued a warning letter to a Connecticut-based manufacturer of vitamins, minerals and herbal extracts for a host of GMP breaches that include failure to test final batches.
A veteran kava researcher says liver toxicity cases that have been reported in recent years may be down to isolated quality control issues, rather than inherent toxicity issues with the herb and its extracts.
Floridian dietary supplements manufacturer Garden of Life has issued a voluntary recall for a vitamin C product after detecting the product was contaminated with soy extracts.
The FDA has issued a warning letter to Florida-based dietary supplement manufacturer Abba Pharma over manufacturing, packaging and labeling violations.
An unauthorized synthetic form of geranium oil – known as 1.3-dimethylpentylamine – remains on-market in major-label dietary supplements, although a retailer crackdown has some “fringe” supplement manufacturers looking for other stimulants to illegally...
US Customs and Border Protection (CBP) and the Food and Drug Administration (FDA) are employing “Predictive Risk-based Evaluation” to target economically motivated adulteration of erectile dysfunction and other unauthorized supplements at US borders.
NSF International’s acquisition of Connecticut-based contract laboratory Pharmalytica Services will allow the company to deliver of a wider range of health science services to the dietary supplements, biotech, pharmaceutical and medical device industries,...
Failing to follow manufacturing records, inappropriate batch production records and poor packaging and label control have been cited by the FDA in a recent post GMP inspection warning letter to a Montana manufacturer.
The introduction of good manufacturing practices (GMPs) is a boon for contract analytical services, and those with special services to offer are standing out from the crowd.
An investigation by Californian firm Anti-Doping Research has revealed the ease with which illegal steroids can be purchased, with them freely available at Amazon.com.
2010 saw the first warning letters from the US Food and Drug Administration (FDA) for supplement Good Manufacturing Practices (GMP) violations, but the overall numbers were down on 2009 levels. FDA legal specialists Ivan Wasserman and La Toya Sutton look...
Setting a specification standard for safe levels of contaminants in omega 3s requires understanding the hazard and correctly measuring exposure in order to assess risk.
NOW Foods has developed a rapid screening test to detect adulterants in dietary supplements, which it hopes will change the perception that dietary supplements are ‘unregulated’.
Freshly issued FDA GMP guidance for small-to-medium sized dietary supplement manufacturers regurgitates a lot of what has already been published in the regulation, but does bring fresh focus to matters such as expiration dates and ingredient supplier...
Long Island-based dietary supplement firm, Hain North America has received a warning letter outlining infringements of Good Management Practice (GMP) from the Food and Drug Administration (FDA).
The Natural Products Association (NPA) has entered the debate about the analytical methods employed by product tester, ConsumerLab, by calling on the product tester to make its standards and methods more transparent.
In the same week the US Food and Drug Administration (FDA) announced an industry-backed crackdown on spiked weight loss, body building and sexual enhancement products, the agency issued an alert against a sulfoaildenafil-contaminated product called Man...
The dietary supplements industry has backed the Food and Drug Administration in cracking down on products tainted with sibutramine, steroids and other substances.
In the midst of a dispute over valerian product testing standards that has escalated into something far more rancorous, the American Herbal Products Association (AHPA) has called on ConsumerLab.com to seek industry counsel over those very same standards.
The bioavailability of certain vitamins in multivitamin and mineral supplements could be improved by using an amino acid and non-digestible oligosaccharide (AAOS) matrix, according to new research.
A herbal erectile dysfunction (ED) dietary supplement has been voluntary withdrawn from the US market by its Floridian manufacturer after it was alerted to a contamination problem with the unauthorized substance, sildenafil.